Key facts
- This page summarizes Joseph J. Ferra Jr.'s Form 4 filing for Elevation Oncology, Inc. (ELEV).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jun 2025, 16:15.
Joseph J. Ferra Jr. - 16 Jun 2025 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)
- Reporting relationship
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- ELEV
- Reported as of
- 16 Jun 2025
- Net transaction value
- -$1,783
- SEC form
- 4
- Accepted by SEC
- 18 Jun 2025, 16:15:13 UTC
- Prior SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Yang, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph J. Ferra Jr. filed Form 4 for Elevation Oncology, Inc. (ELEV) on 18 Jun 2025.
Change
- Previous filing in this sequence was filed on 19 May 2025.
- Current net transaction value: -$1,783.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001733790
Primary reporting owner
Ferra Joseph J Jr
- Relationship
- CHIEF EXECUTIVE OFFICER, Director
- Address
- C/O ELEVATION ONCOLOGY, INC., 101 FEDERAL STREET, SUITE 1900, BOSTON
- Signature
- /s/ Robert Yang, Attorney-in-Fact
- Signature date
- 18 Jun 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELEV
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +12,560
- Change %
- +9.2%
- Price
- Shares after
- 149,712
- Date
- 16 Jun 2025
- Ownership
- Direct
- Footnotes
- F1
ELEV
transaction
Common Stock
Tax liability
- Transaction value
- $1,783
- Shares
- -4,627
- Change %
- -3.1%
- Price
- $0.3854
- Shares after
- 145,085
- Date
- 16 Jun 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELEV
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -12,560
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 16 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,560
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
25% of the RSUs vested on June 16, 2022, and the remainder vested as to 1/16 of the total RSUs quarterly.
Footnote F3
The RSUs do not expire; they either vest or are canceled prior to the vesting date.